Affordable Access

Access to the full text

Mortality risk estimation in acute calculous cholecystitis: beyond the Tokyo Guidelines

Authors
  • González-Castillo, Ana María1, 2
  • Sancho-Insenser, Juan1, 2
  • De Miguel-Palacio, Maite2
  • Morera-Casaponsa, Josep-Ricard1
  • Membrilla-Fernández, Estela1, 2
  • Pons-Fragero, María-José2
  • Pera-Román, Miguel1, 2
  • Grande-Posa, Luis1, 2
  • 1 Autonomous University of Barcelona, Passeig Marítim de la Barceloneta, 25-29, Barcelona, 08003, Spain , Barcelona (Spain)
  • 2 Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain , Barcelona (Spain)
Type
Published Article
Journal
World Journal of Emergency Surgery
Publisher
Springer (Biomed Central Ltd.)
Publication Date
May 11, 2021
Volume
16
Issue
1
Identifiers
DOI: 10.1186/s13017-021-00368-x
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundAcute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments. The recommended treatment is the early laparoscopic cholecystectomy; however, the Tokyo Guidelines (TG) advocate for different initial treatments in some subgroups of patients without a strong evidence that all patients will benefit from them. There is no clear consensus in the literature about who is the unfit patient for surgical treatment. The primary aim of the study is to identify the risk factors for mortality in ACC and compare them with Tokyo Guidelines (TG) classification.MethodsRetrospective unicentric cohort study of patients emergently admitted with and ACC during 1 January 2011 to 31 December 2016. The study comprised 963 patients. Primary outcome was the mortality after the diagnosis. A propensity score method was used to avoid confounding factors comparing surgical treatment and non-surgical treatment.ResultsThe overall mortality was 3.6%. Mortality was associated with older age (68 + IQR 27 vs. 83 + IQR 5.5; P = 0.001) and higher Charlson Comorbidity Index (3.5 + 5.3 vs. 0+2; P = 0.001). A logistic regression model isolated four mortality risk factors (ACME): chronic obstructive pulmonary disease (OR 4.66 95% CI 1.7–12.8 P = 0.001), dementia (OR 4.12; 95% CI 1.34–12.7, P = 0.001), age > 80 years (OR 1.12: 95% CI 1.02–1.21, P = 0.001) and the need of preoperative vasoactive amines (OR 9.9: 95% CI 3.5–28.3, P = 0.001) which predicted the mortality in a 92% of the patients. The receiver operating characteristic curve yielded an area of 88% significantly higher that 68% (P = 0.003) from the TG classification. When comparing subgroups selected using propensity score matching with the same morbidity and severity of ACC, mortality was higher in the non-surgical treatment group. (26.2% vs. 10.5%).ConclusionsMortality was higher in ACC patients treated with non-surgical treatment. ACME identifies high-risk patients. The validation to ACME with a prospective multicenter study population could allow us to create a new alternative guideline to TG for treating ACC.Trial registrationRetrospectively registered and recorded in Clinical Trials. NCT04744441

Report this publication

Statistics

Seen <100 times